‘Breakthrough’ Alzheimer’s drugs unlikely to benefit patients, report suggests

A major review has provoked a backlash after concluding the medicines provide too little benefit to be noticed.

MOSAEC
Author: MOSAEC

Source: BBC.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *